| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/07/2002 | WO2002017707A1 An improved process for cultivation of algae |
| 03/07/2002 | WO2001094420B1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 03/07/2002 | WO2001088165A8 Nucleotide sequences coding for signal transduction components involved in plant pathogen defence |
| 03/07/2002 | WO2001080810A9 Chondroitin synthase gene and methods of making and using same |
| 03/07/2002 | WO2001079269A3 Lipid binding protein 4 |
| 03/07/2002 | WO2001078757A3 Reversible immortalization |
| 03/07/2002 | WO2001077181A3 Anti-rhesus d monoclonal antibodies |
| 03/07/2002 | WO2001074855A3 Compositions and methods for dendritic cell-based immunotherapy |
| 03/07/2002 | WO2001066697A3 Serum free cultivation of primate embryonic stem cells |
| 03/07/2002 | WO2001064838A3 Thermophilic dna polymerases from thermoactinomyces vulgaris |
| 03/07/2002 | WO2001060983A3 Treatment for bone disorders |
| 03/07/2002 | WO2001059130A3 Proteins producing an altered immunogenic response and methods of making and using the same |
| 03/07/2002 | WO2001058956A3 Antibodies that bind human interleukin-18 and methods of making and using |
| 03/07/2002 | WO2001058949A3 Heterologous polypeptide of the tnf family |
| 03/07/2002 | WO2001057233A3 Methods and materials relating to preadipocyte factor-1-like (pref-1-like) polypeptides and polynucleotides |
| 03/07/2002 | WO2001055178A3 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 03/07/2002 | WO2001053468A3 Lipid metabolism enzymes and polynucleotides encoding them |
| 03/07/2002 | WO2001051636A3 Secreted proteins |
| 03/07/2002 | WO2001051618A3 Purification of microglial cells |
| 03/07/2002 | WO2001051093A3 METHODS OF INCREASING THE GLUCOSE RESPONSIVENESS OF PANCREATIC β-CELLS |
| 03/07/2002 | WO2001046231A3 Polynucleotides and polypeptides encoded thereby |
| 03/07/2002 | WO2001040474A3 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 03/07/2002 | WO2001038360A3 Novel hcv non-structural polypeptide |
| 03/07/2002 | WO2001034774A3 Method for protection of mammalian cells by means of over-expressed g-2/m cell cycle coupler |
| 03/07/2002 | WO2001032888A3 Human transferase molecules |
| 03/07/2002 | WO2001031008A3 Human and rat fgf-20 genes and gene expression products |
| 03/07/2002 | WO2001031006A3 Serum amyloid a isoform from colostrum |
| 03/07/2002 | WO2001029220A3 Mage-a12 antigenic peptides and uses thereof |
| 03/07/2002 | WO2001021654A3 Syk kinase-associated cell cycle proteins, compositions and methods of use |
| 03/07/2002 | WO2001019870A3 Secreted soluble alpha2delta-2, alpha2delta-3, alpha2delta-4 calcium channel subunit polypeptides and screening assays using same |
| 03/07/2002 | WO2000073344A9 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
| 03/07/2002 | WO2000056352A3 Reagents and methods useful for detecting diseases of the prostate |
| 03/07/2002 | US20020029395 Flowering locus T (FT) and genetically modified plants having delayed flower development |
| 03/07/2002 | US20020028915 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/07/2002 | US20020028914 Chimeric toxins for targeted therapy |
| 03/07/2002 | US20020028515 Methods for use of delivery composition for expanding, activating, committing or mobilizing one or more pluripotent, self-renewing and committed stem cells |
| 03/07/2002 | US20020028514 Recombinant AAV vector-based transduction system and use of same |
| 03/07/2002 | US20020028513 P element derived vector and methods for its use |
| 03/07/2002 | US20020028512 Auxin sensitizer |
| 03/07/2002 | US20020028511 Apparatus for use in generation of bone; for use in orthepedics, dentistry and surgery |
| 03/07/2002 | US20020028510 Cells for use in the treatment of nervous system disorders |
| 03/07/2002 | US20020028509 Freeze drying; complex of growth factor and corticoids |
| 03/07/2002 | US20020028495 Deoxyribonuclease II beta proteins and cDNAs |
| 03/07/2002 | US20020028493 Device for tissue engineering a bone equivalent |
| 03/07/2002 | US20020028487 Polypeptide; for use in detection of cell cycle modulators |
| 03/07/2002 | US20020028484 Expression vector for use in the treatment and prevention of viral diseases |
| 03/07/2002 | US20020028449 26 Human secreted proteins |
| 03/07/2002 | US20020028436 Suppression of leukocyte transferring in humans; administer immunoglobulins to humans, detect bound receptor, evaluate immune response |
| 03/07/2002 | US20020028433 Systems for sensitive detection of G-protein coupled receptor and orphan receptor function using reporter enzyme mutant complementation |
| 03/07/2002 | US20020028432 Side effect reduction using quencher; storage stability |
| 03/07/2002 | US20020028212 Recombinant viruses coding for a glutamate decarboxylase (gad) activity |
| 03/07/2002 | US20020028207 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 03/07/2002 | US20020028205 May be comprised of a heavily glycosylated mucin part, which mediates binding to selectins, such as PSGL-1; absorber to prevent a hyperacute rejection of a xenotransplant |
| 03/07/2002 | US20020028204 Inhibits ristocetin-induced platelet aggregation), botrocetin-induced platelet aggregation, and shear stress-induced platelet aggregation of human platelet, and which does not express bleeding action |
| 03/07/2002 | US20020028202 Common gamma chain blocking agents |
| 03/07/2002 | US20020028192 Non-contracting tissue equivalent |
| 03/07/2002 | DE10038722A1 Verfahren zur Reduzierung von spezifischen Immunreaktionen A process for the reduction of specific immune responses |
| 03/07/2002 | CA2457165A1 Methods for preparing human thrombopoietin polypeptides by mammalian cell cultures |
| 03/07/2002 | CA2457162A1 Electroprocessed fibrin-based matrices and tissues |
| 03/07/2002 | CA2424052A1 Packaging of positive-strand rna virus replicon particles |
| 03/07/2002 | CA2421063A1 Methods for stable transduction of cells with viral vectors |
| 03/07/2002 | CA2420877A1 Isomaltulose synthase |
| 03/07/2002 | CA2420876A1 A recombinant monoclonal antibody to phosphotyrosine-containing proteins |
| 03/07/2002 | CA2420867A1 Methods for enhancing the efficacy of cancer therapy |
| 03/07/2002 | CA2420856A1 Control of crop pests and animal parasites through direct neuronal uptake |
| 03/07/2002 | CA2420765A1 Anti-angiogenic peptides |
| 03/07/2002 | CA2420724A1 Transgenic plants containing molecular decoys that alter protein content therein |
| 03/07/2002 | CA2420696A1 Isolated human drug-metabolizing proteins, nucleic acid molecules and uses thereof |
| 03/07/2002 | CA2420659A1 Genes expressed in the cell cycle |
| 03/07/2002 | CA2420591A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/07/2002 | CA2420276A1 Differentially expressed epitopes and uses thereof |
| 03/07/2002 | CA2420105A1 Human kinases |
| 03/07/2002 | CA2419851A1 Genetic demonstration of requirement for nkx6.1, nkx2.2 and nkx6.2 in ventral neuron generation |
| 03/07/2002 | CA2419342A1 G-protein coupled receptors |
| 03/07/2002 | CA2419275A1 Butinol i esterase |
| 03/07/2002 | CA2419251A1 Nucleic acid constructs including a novel t-cell active promoter, and pharmaceutical compositions and methods utilizing same for regulating t-cell mediated immune response |
| 03/07/2002 | CA2419152A1 Methods of using agents that modulate bone formation and inhibit adipogenesis |
| 03/07/2002 | CA2417233A1 Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents |
| 03/06/2002 | EP1184461A2 Creation of gene targeting vectors using homologous recombination in yeast |
| 03/06/2002 | EP1184458A1 Differentially expressed CD46 epitopes, proteinaceous molecules capable of binding thereto, and uses thereof |
| 03/06/2002 | EP1184454A2 Nav2 channel gene-deficient non-human animals |
| 03/06/2002 | EP1184391A2 Acetylcholine receptor subunits |
| 03/06/2002 | EP1184390A2 Acetylcholine receptor subunits |
| 03/06/2002 | EP1183533A1 Test system for in-vitro detection of an antigen-specific immune response |
| 03/06/2002 | EP1183386A1 Tm4sf receptors |
| 03/06/2002 | EP1183384A1 Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders |
| 03/06/2002 | EP1183382A2 Method for selecting improved vectors |
| 03/06/2002 | EP1183381A2 Synthetic gene for expressing active retroviral protein in eukaryotes |
| 03/06/2002 | EP1183380A1 Compositions and methods useful for production of recombinant viruses which require helper viruses |
| 03/06/2002 | EP1183376A1 Isoflavonoid methylation enzyme |
| 03/06/2002 | EP1183370A2 Human oxidoreductase proteins |
| 03/06/2002 | EP1183367A1 Cytotoxic t-cell epitopes of the papillomavirus l1-protein and use thereof in diagnostics and therapy |
| 03/06/2002 | EP1183364A1 Groel muteins with improved stability |
| 03/06/2002 | EP1183362A1 Il-1 eta dna and polypeptides |
| 03/06/2002 | EP1183359A2 Nucleic acids and proteins with interferon-beta activity |
| 03/06/2002 | EP1183356A2 Gustatory receptors in drosophila |
| 03/06/2002 | EP1183355A1 T-bet compositions and methods of use thereof |
| 03/06/2002 | EP1183353A1 Modified chimeric polypeptides with improved pharmacokinetic properties |
| 03/06/2002 | EP1183351A1 Phospholipid transfer protein |
| 03/06/2002 | EP1183350A2 Expression products of genes involved in diseases related to cholesterol metabolism |